Clinical Trial Update: SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing GEO-CM04S1 vaccine to an mRNA SARS-CoV-2 vaccine in patients with hematologic malignancies; the study is currently active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Leukemia
• Lymphoma
• Multiple Myeloma

Drugs mentioned

• GEO-CM04S1
• mRNA SARS-CoV-2 Vaccine

Snippet

Sponsor: GeoVax, Inc. | Conditions: COVID-19 Infection, Hematopoietic and Lymphoid System Neoplasm | Phase 2 | Status: ACTIVE_NOT_RECRUITING